Offer - Urjas Oil for just ₹ 1 X
Zidolam N is a prescription drug, available for use as Tablet. The alternative uses of Zidolam N have also been explained below.
The optimal dosage of Zidolam N is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
While these are the most often observed Zidolam N side effects, there are can be others also. These have been listed below. Such side effects of Zidolam N normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Zidolam N is Safe for pregnant women and Safe for women who are breastfeeding. Further, the section on Zidolam N related warnings talks about Zidolam N's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Kidney Disease, Pancreatitis, Kidney Disease must refrain from the use of Zidolam N since this can cause severe adverse effects. The section on Zidolam N contraindications lists all such conditions.
Additionally, Zidolam N may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Zidolam N, it is important to know that it is not safe while driving, and is not habit-forming.
Zidolam N is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Zidolam N safe for pregnant women?
Pregnant women can take Zidolam N safely.
Is the use of Zidolam N safe during breastfeeding?
Breastfeeding women can safely use Zidolam N.
What is the effect of Zidolam N on the Kidneys?
There are no side effects of Zidolam N on the kidneys.
What is the effect of Zidolam N on the Liver?
Zidolam N is rarely harmful for the liver.
What is the effect of Zidolam N on the Heart?
Zidolam N is completely safe for the heart.
Zidolam N should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Zidolam N unless your doctor advises you to do so -
Is this Zidolam N habit forming or addictive?
Zidolam N is not addictive in nature.
Interaction between Food and Zidolam N
You can take Zidolam N with food.
Interaction between Alcohol and Zidolam N
Due to lack of research, there is no information about the side effects of taking Zidolam N with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Epivir (lamivudine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 807-808
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 96-99
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Retrovir® (zidovudine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 806-807
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1286-1288
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Viramune® (nevirapine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 809